Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Michihito Onishi
Chief Business Officer

Message the company or request a 1:1 meeting here

HISHOH Biopharma Co., Ltd. is a biotech company founded in 2021 in Japan and develops HSO-001, a novel synthetic compound licensed from Daiichi Sankyo, for treatment of allergic rhinitis through allergen immunotherapy.